PUK23 METHODOLOGICAL CONSIDERATIONS FOR COST-EFFECTIVENESS ANALYSIS OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY
Abstract
Authors
D. Globe J. Carlson H. Patel D. Colayco R.N. Hansen J. Watanabe S.D. Sullivan